Polyhexamethylene biguanide (0.02%) alone is not adequate for treating chronic Acanthameoba keratitis [16]

Eye

Volumn 14, Issue 4, 2000, Pages 678-679

  Lam, D S C ^a   Lyon, D ^a   Poon, A S Y ^a   Rao, S K ^a   Fan, D S P ^a   Houang, E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; HEXAMIDINE; NEOMYCIN; PAROMOMYCIN; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE;

ACANTHAMOEBA KERATITIS; ANTIBIOTIC SENSITIVITY; CASE REPORT; CATARACT; CATARACTOGENESIS; CHRONIC DISEASE; CORNEA OPACITY; GLAUCOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LETTER; PERSISTENT INFECTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0033846640     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.2000.174     Document Type: Letter

References (9)

1. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide
2. Acanthamoeba keratitis
3. Acanthamoeba keratitis: Resistance to medical therapy
4. Combined treatment of Acanthamoeba keratitis with propamidine, neomycin and polyhexamethylene biguanide
5. Outbreaks of keratitis presumed to be caused by Acanthamoeba
6. Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?
7. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide
8. Confocal microscopy findings of Acanthamoeba keratitis
9. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine